Antidepressant monotherapy for bipolar type II major depression

Bipolar Disorders

Volumn 5, Issue 6, 2003, Pages 388-395

  Amsterdam, Jay D ^a   Brunswick, David J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antidepressant; Bipolar II disorder; Mood stabilizer; Treatment

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ALCOHOLISM; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; HYPOMANIA; INCIDENCE; LONG TERM CARE; MAJOR DEPRESSION; MANIA; MENTAL DISEASE; MONOTHERAPY; MORBIDITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RAPID CYCLING BIPOLAR DISORDER; RECURRENT DISEASE; REVIEW; SUICIDE; UNITED STATES;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; CLINICAL TRIALS; CYCLOHEXANOLS; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; PRACTICE GUIDELINES; SEROTONIN UPTAKE INHIBITORS;

EID: 0346656778     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-5618.2003.00066.x     Document Type: Review

References (62)

1. Robins LN, Regier DA. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press, 1991.
2. Simpson SG, Folstein SE, Meyers DA, McMahon FJ, Brusco DM, DePauo JR Jr Bipolar II: the most common bipolar phenotype. Am J Psychiatry 1993; 150: 901-903.
3. Goodwin FK, Ghaemi SN. Understanding manic-depressive illness. Arch Gen Psychiatry 1998; 55: 23-25.
4. Goodwin FK, Jamison KR. Manic Depressive Illness. New York: Oxford University Press, 1990.
5. Weissman MM, Myers JK. Affective disorders in a US urban community: the use of Research Diagnostic Criteria in an epidemiological survey. Arch Gen Psychiatry 1978; 35: 1304-1311.
6. Hantouche EG, Akiskal HS, Lancrenon S et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord 1998; 50: 163-173.
7. Benazzi F. Bipolar II disorder is common among depressed outpatients. Psychiat Clin Neurosci 1999; 53: 607-609.
8. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord 1997; 43: 163-166.
9. Dunner DL, Fleiss JL, Fieve RR. The course of development of mania in patients with recurrent depression. Am J Psychiatry 1976; 133: 905-908.
10. Akiskal HS, Maser JD, Zeller PJ et al. Switching from "unipolar" to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995; 52: 114-123.
11. Ayuso-Gutierrez JL, Ramos-Brieva JA. The course of manic-depressive illness: a comparative study of bipolar I and bipolar II patients. J Affect Disord 1982; 4: 9-14.
12. Coryell W, Endicott J, Maser JD, Keller MB, Leon AC, Akiskal HS. Long-term stability of polarity distinctions in the affective disorders. Am J Psychiatry 1995; 152: 385-390.
13. Winokur G, Coryell W, Keller M, Endicott J, Akiskal H. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993; 50: 457-465.
14. Cassano GB, Dell'Osso L, Frank E et al. The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord 1999; 54: 319-328.
15. Akiskal H. The spectrum of bipolar disorder beyond DSM. J Clin Psychopharmacol 1996; 16 (Suppl. 1): 4S-14S.
16. Kupfer DJ, Carpenter LL, Frank E. Is bipolar II a unique disorder? Compr Psychiatry 1988; 29: 228-236.
17. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991; 159: 123-129.
18. Endicott J, Nee J, Andreasen N, Clayton P, Keller M, Coryell W. Bipolar II: combine or keep separate? J Affect Disord 1985; 8: 17-28.
19. Dunner DL. Sub-types of bipolar affective disorder with particular regard to bipolar II. Psychiatry Dev 1983; 1: 75-85.
20. Akiskal HS, Cassano GB, Musetti L, Perugi G, Tundo A, Mignani V. Psychopathology, temperament, and past course in primary major depressions. 1. Review of evidence for a bipolar spectrum. Psychopathology 1989; 22: 268-277.
21. Dunner DL. Bipolar disorders in DSM-IV: impact of inclusion of rapid cycling as a course modifier. Neuropsychopharmacology 1998; 19: 189-193.
22. Prien RF, Klett CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29: 420-425.
23. Prien RF, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984; 41: 1096-1104.
24. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36: 555-559.
25. Sachs GS, Lafer B, Stoll AL et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994; 55: 391-393.
26. Bottlender R, Rudolf D, Strauss A, Moller HJ. Mood-stabilizers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 2001; 63: 79-83.
27. Boerlin HL, Gitlin M, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374-379.
28. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50: 448-455.
29. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403-1411.
30. Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4: 313-322.
31. Howland RH. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425-427.
32. Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988; 145: 804-808.
33. Saletu B, Schjerve M, Grunberger J, Schanda H, Arnold OH. Fluvoxamine - a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients. J Neural Transm 1977; 41: 17-36.
34. Benfield P, Heel RC, Lewis SP. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32: 481-508.
35. Simpson SG, DePaulo JR. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol 1991; 11: 52-54.
36. Maj M. Selection of the initial drug(s) in the treatment of bipolar disorder, depressed phase. Mod Probl Pharmacopsychiatry 1997; 25: 66-77.
37. Peet M. Induction of mania with serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994; 164: 549-550.
38. Amsterdam JD, Garcia-Espana F, Fawcett J et al. Efficacy and safety of fluoxetine in bipolar II major depressive episode. J Clin Psychopharmacol 1998; 18: 435-440.
39. Benazzi F. Antidepressant-associated hypomania in out-patient depression: a 203-case study in private practice. J Affect Disord 1997; 46: 73-77.
40. Montgomery SA, Schatzberg AF, Guelfi JD et al. Pharmacotherapy of depression and mixed states in bipolar disorder. J Affect Disord 2000; 59: S39-S56.
41. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151 (Suppl. 1): 36.
42. Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976; 133: 925-929.
43. Quitkin FM, Kane JM, Rifkin A et al. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression: a prospective, placebo-controlled comparison. Psychopharm. Bull 1981; 17: 142-144.
44. Ghaemi SN, Sachs GS, Chiou AM, Pandurangi AK, Goodwin FK. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord 1999; 52: 135-144.
45. Treatment of bipolar disorder. The Expert Consensus Panel for Bipolar Disorder. J Clin Psychiatry 1996; 57 (Suppl. 12A): 2-89.
46. Yatham LN, Kusumakar V, Parikh SV et al. Bipolar depression: treatment options. Can J Psychiatry 1997; 42 (Suppl. 2): 87S-91S.
47. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. Medication Treatment of Bipolar Disorder 2000. Postgraduate Medicine Special Report, April 2000.
48. Keck PE Jr, McElroy SL. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996; 16 (Suppl. 1): 15S-23S.
49. Sharma V, Mazmanian DS, Persad E, Kueneman KM. Treatment of bipolar depression: a survey of Canadian psychiatrists. Can J Psychiatry 1997; 42: 298-302.
50. Dantzler A, Osser DN. Algorithms for the pharmacotherapy of acute depression in patients with bipolar disorder. Psychiatry Ann 1999; 29: 270-284.
51. Amsterdam JD. Efficacy and safety of venlafaxine in bipolar type-II major depressive episode. J Clin Psychopharmacol 1998; 18: 414-417.
52. Amsterdam JD, Hooper M, Amchin J. Efficacy and safety of once vs. twice daily venlafaxine in patients with major depression. J Clin Psychiatry 1998; 59: 236-240.
53. Roy-Byrne P, Post RM, Uhde TW, Porcu T, Davis D. The longitudinal course of affective illness: life chart data from research patients at the NIMH. Acta Psychiatry Scand 1985; 71 (Suppl. 317): 1-34.
54. Coryell W, Endicott J, Kelly M. Rapid cycling affective disorder: demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49: 126-131.
55. Bauer MS, Calabrese J, Dunner DJ et al. Multisite data reanalysis of the validity of rapid cycling as a course for bipolar disorder in DSM IV. Am J Psychiatry 1994; 151: 506-515.
56. McElroy SL, Keck PE Jr, Pope HG Jr, Hudson JI, Faeddam GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149: 1633-1644.
57. Wehr TA, Sack D, Rosenthal N, Cowdry RmW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 79-184.
58. Amsterdam JD, Garcia-Espana F. Venlafaxine monotherapy in women with bipolar II depression. J Affec Disord 2000; 59: 225-229.
59. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
60. Himmelhoch JM, Thase ME, Mallinger AG et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148: 910-916.
61. Amsterdam JD. Use of high dose tranylcypromine in resistant depression. In: Amsterdam J ed. Refractory Depression. New York: Raven Press Ltd, 1991: 123-130.
62. Vieta E, Gasto C, Otero A, Nieto E, Vallejo J. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997; 38: 98-101.